Characterisation of an industrial affinity process used in the manufacturing of digoxin-specific polyclonal Fab fragments

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 848, Issue 1, 2007, Pages 88-96

  Thillaivinayagalingam, Pranavan ^a   O'Donovan, Kieran ^b   Newcombe, Anthony R ^b   Keshavarz Moore, Eli ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b BIOCOMPATIBLES UK LTD   (United Kingdom)

Author keywords

Affinity purification; Antibody; Chromatography; Confocal scanning laser microscopy

Indexed keywords

CHROMATOGRAPHIC ANALYSIS; CONFOCAL MICROSCOPY; DISTILLATION COLUMNS; DRUG PRODUCTS; PURIFICATION;

AFFINITY MATRIX; AFFINITY PURIFICATION; BIOTHERAPEUTICS; CONFOCAL SCANNING LASER MICROSCOPY; MATRIX CAPACITY;

ANTIBODIES;

DIGOXIN ANTIBODY F(AB) FRAGMENT;

AFFINITY CHROMATOGRAPHY; ARTICLE; CALCULATION; CONFOCAL LASER MICROSCOPY; DRUG BINDING; DRUG MANUFACTURE; DRUG PURIFICATION; DRUG PURITY; DRUG UPTAKE; FEASIBILITY STUDY; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY AFFINITY; CHROMATOGRAPHY, AFFINITY; DRUG INDUSTRY; ELECTROPHORESIS, POLYACRYLAMIDE GEL; IMMUNOGLOBULIN FAB FRAGMENTS; MICROSCOPY, CONFOCAL; SHEEP;

OVIS;

EID: 33947116961     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2006.03.065     Document Type: Article

References (21)

1. Newcombe A.R., Cresswell C., Davies S., Watson K., Harris G., O'Donovan K., and Francis R. J. Chromatogr. B 814 (2005) 209
2. Haurum J., and Bregenholt S. IDrugs 8 (2005) 404
3. L. Gray, C-088V Dynamic antibody industry. Including polyclonals and monoclonals, Business communication company Inc., Norwalk, 2002, www.bccresearch.com/biotech/c088v.html.
4. Follman D.K., and Fahrner R.L. J. Chromatogr. A 1024 (2004) 79
5. Safadi R., Levy I., Amitai Y., and Caraco Y. Arch. Intern. Med. 155 (1995) 2121
6. Flanagan R.J., and Jones A.L. Drug Saf. 27 (2004) 1115
7. Smith T.W. Am. J. Emerg. Med. 9 (1991) 1
8. Protherics UK Ltd., Blaenwaun, Ffostrasol, Llandysul, Ceredigion, Wales, UK, www.protherics.com.
9. McMillin A.G., Owen W.E., Lambert T.L., De B.K., Frank E.L., Bach P.R., Annesley T.M., and Roberts W.L. Clin. Chem. 48 (2002) 1580
10. Ljunglof A., and Hjorth R. J. Chromatogr. A 743 (1996) 75
11. Ljunglof A., and Thommes J. J. Chromatogr. A 813 (1998) 387
12. Ljunglof A., Larsson M., Knuuttila K.G., and Lindgren J. J. Chromatogr. A 893 (2000) 235
13. Ljunglof A., Bergvall P., Bhikhabhai R., and Hjorth R. J. Chromatogr. A 844 (1999) 129
14. Cresswell C., Newcombe A.R., Davies S., Macpherson I., Nelson P., O'Donovan K., and Francis R. Biotechnol. Appl. Biochem. 42 (2005) 163
15. Wheelwright S.M. Protein Purification Design and Scale up of Downstream Processing (1991), Hanser Publishers, New York
16. Sofer G., and Hagel L. Handbook of Process Chromatography. A Guide to Optimisation, Scale-up and Validation (1997), London Academic press, San Diego pp. 100-106 and 289-298
17. Suen S.Y. J. Chem. Technol. Biotechnol. 70 (1997) 278
18. Aquino L.C.L., Miranda E.A., Duarte I.S., Rosa P.T.V., and Bueno S.M.A. Braz. J. Chem. Eng. 20 (2003) 3
19. Mao Q.M., and Hearn M.T.W. Biotechnol. Bioeng. 52 (1996) 204
20. Blanco R., Arai A., Grinberg N., Yarmush M., and Karger B.L. J. Chromatogr. 482 (1989) 1
21. Amitava D., Alice W., and Pradip D. Ther. Drug Monit. 21 2 (1999) 251